Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Special Sections
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Submit
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn
Research ArticleArticle

Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay

Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
Journal of Pharmacology and Experimental Therapeutics January 1999, 288 (1) 348-357;
Stephan Döppenschmitt
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Peter Langguth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carl Gunnar Regårdh
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tommy B. Andersson
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Constanze Hilgendorf
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hildegard Spahn-Langguth
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • eLetters
  • PDF
Loading

Article Information

vol. 288 no. 1 348-357
PubMed 
9862789

Published By 
American Society for Pharmacology and Experimental Therapeutics
Print ISSN 
0022-3565
Online ISSN 
1521-0103
History 
  • Received February 20, 1998
  • Accepted July 20, 1998
  • Published online January 1, 1999.

Copyright & Usage 
The American Society for Pharmacology and Experimental Therapeutics

Author Information

  1. Stephan Döppenschmitt1,2,
  2. Peter Langguth2,3,
  3. Carl Gunnar Regårdh2,
  4. Tommy B. Andersson2,
  5. Constanze Hilgendorf1 and
  6. Hildegard Spahn-Langguth1
  1. 1School of Pharmacy, Martin-Luther-University Halle-Wittenberg, Halle (Saale), Germany (S.D., C.H., H.S.-L.); 2Astra Hässle AB, Mölndal, Sweden (S.D., P.L., C.G.R., T.B.A.); and 3School of Pharmacy, Johannes Gutenberg University, Mainz, Germany (P.L.)
    View Full Text

    Statistics from Altmetric.com

    Article usage

    Article usage:

    No statistics are available.

    PreviousNext
    Back to top

    In this issue

    Journal of Pharmacology and Experimental Therapeutics: 288 (1)
    Journal of Pharmacology and Experimental Therapeutics
    Vol. 288, Issue 1
    1 Jan 1999
    • Table of Contents
    • About the Cover
    • Index by author
    Download PDF
    Article Alerts
    Sign In to Email Alerts with your Email Address
    Email Article

    Thank you for sharing this Journal of Pharmacology and Experimental Therapeutics article.

    NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

    Enter multiple addresses on separate lines or separate them with commas.
    Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay
    (Your Name) has forwarded a page to you from Journal of Pharmacology and Experimental Therapeutics
    (Your Name) thought you would be interested in this article in Journal of Pharmacology and Experimental Therapeutics.
    CAPTCHA
    This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
    Citation Tools
    Research ArticleArticle

    Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay

    Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
    Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 348-357;

    Citation Manager Formats

    • BibTeX
    • Bookends
    • EasyBib
    • EndNote (tagged)
    • EndNote 8 (xml)
    • Medlars
    • Mendeley
    • Papers
    • RefWorks Tagged
    • Ref Manager
    • RIS
    • Zotero

    Share
    Research ArticleArticle

    Characterization of Binding Properties to Human P-Glycoprotein: Development of a [3H]Verapamil Radioligand-Binding Assay

    Stephan Döppenschmitt, Peter Langguth, Carl Gunnar Regårdh, Tommy B. Andersson, Constanze Hilgendorf and Hildegard Spahn-Langguth
    Journal of Pharmacology and Experimental Therapeutics January 1, 1999, 288 (1) 348-357;
    del.icio.us logo Digg logo Reddit logo Twitter logo Facebook logo Google logo Mendeley logo
    • Tweet Widget
    • Facebook Like
    • Google Plus One

    Jump to section

    • Article
      • Abstract
      • Materials and Methods
      • Results
      • Discussion
      • Acknowledgments
      • Footnotes
      • References
    • Figures & Data
    • Info & Metrics
    • eLetters
    • PDF

    Related Articles

    Cited By...

    More in this TOC Section

    • CRV431 Decreases Liver Fibrosis and Tumor Development
    • Tissue Selectivity of Antidiabetic Agent Nateglinide: Study on Cardiovascular and β-Cell KATP Channels
    • Distribution in Rat Brain of Binding Sites of Kaliotoxin, a Blocker of Kv1.1 and Kv1.3 α-Subunits
    Show more Article

    Similar Articles

    Advertisement
    • Home
    • Alerts
    Facebook   Twitter   LinkedIn   RSS

    Navigate

    • Current Issue
    • Fast Forward by date
    • Fast Forward by section
    • Latest Articles
    • Archive
    • Search for Articles
    • Feedback
    • ASPET

    More Information

    • About JPET
    • Editorial Board
    • Instructions to Authors
    • Submit a Manuscript
    • Customized Alerts
    • RSS Feeds
    • Subscriptions
    • Permissions
    • Terms & Conditions of Use

    ASPET's Other Journals

    • Drug Metabolism and Disposition
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    ISSN 1521-0103 (Online)

    Copyright © 2022 by the American Society for Pharmacology and Experimental Therapeutics